Conditional Gene Knockout in Human Cells with Inducible CRISPR/Cas9.

Area of Science:

• Molecular Biology
• Genetics
• Stem Cell Biology

Background:

• CRISPR/Cas9 technology has transformed genetic engineering.
• Conventional gene knockouts are limited for studying dynamic processes like development or disease progression.
• Stage-specific gene function analysis requires precise control over gene silencing.

Purpose of the Study:

• To introduce a CRISPR/Cas9-based Optimized inducible gene KnockOut (OPTiKO) method for conditional loss-of-function studies in human cells.
• To enable the study of gene function in a time- and condition-dependent manner.
• To facilitate research in developmental biology and disease modeling.

Main Methods:

• Development of the OPTiKO system utilizing CRISPR/Cas9.
• Implementation of an improved tetracycline-inducible system for conditional single guide RNA (sgRNA) expression.
• Genetic engineering of the AAVS1 genomic safe harbor for stable and homogeneous transgene expression.
• Application in human pluripotent stem cells (hPSCs) and their derivatives.

Main Results:

• The OPTiKO method allows for efficient and conditional gene knockout in human cells.
• Stable and homogeneous transgene expression was achieved through AAVS1 safe harbor integration.
• The system is applicable to human pluripotent stem cells and various differentiated cell types.
• Enables investigation of gene function across different developmental stages and disease contexts.

Conclusions:

• The OPTiKO system provides a powerful tool for conditional gene function studies in human cells.
• This method overcomes limitations of conventional gene knockouts for dynamic biological processes.
• OPTiKO is versatile and applicable to diverse cell types and research areas, including development and disease modeling.